Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Stress Disorders, Post-Traumatic 2Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obsessive-Compulsive Disorder 1Neoplasms 1Melanoma, Cutaneous Malignant 1Anxiety Disorders 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Eye Movement Desensitization Reprocessing × Clear all
NCT07447089 2026-03-04

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Università Cattolica di Milano

Phase NA Recruiting
25 enrolled
Head & Neck

Neoplasms, Stress Disorders, Post-Traumatic, Thyroid Neoplasms

NCT06767332 2025-01-09

FAME

Leiden University Medical Center

Phase NA Recruiting
30 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Anxiety Disorders

NCT06110702 2024-04-16

MDL

University of Pisa

Phase NA Completed
287 enrolled
LymphoidOther hematologic neoplasm

Obsessive-Compulsive Disorder, Stress Disorders, Post-Traumatic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡